Apr 26, 2026, 11:42
FDA Update on Hormone Therapy Safety Warnings – JAMA
JAMA shared a post on LinkedIn:
“Perspective: FDA removal of most black box warnings for menopausal hormone therapy enables individualized menopause symptom management; estrogen-only therapy retains a warning for endometrial cancer risk in women with a uterus.”
Title: Opportunity for Improved Menopausal Hormone Therapy Prescribing
Authors: Deborah Bartz, Ananya Tadikonda, JoAnn E. Manson
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 26, 2026, 11:54Christopher Robinson: Predicting Neonatal Infection in Preterm Rupture of Membranes
-
Apr 26, 2026, 11:47Rüdiger Klapdor: Endometriosis Education Truly Comes Alive at EEC 2026
-
Apr 26, 2026, 11:36Hiroki Ozawa: New Guideline Updates on Pregnancy in Rheumatic Diseases
-
Apr 26, 2026, 11:32From Inflammation to Scar Tissue: How Endometriosis Can Affect Reproduction – Endometriosis Foundation of America
-
Apr 26, 2026, 08:03Swagata Goswami: A Journey of Hope, 7 Blastocysts, 2 Chances, One Dream
-
Apr 26, 2026, 07:57Gaity Ahmad: When Patient Safety Becomes a Barrier to Care
-
Apr 26, 2026, 07:52Christopher Robinson: Uterine Incision-to-Delivery Interval and Neonatal Outcomes Among Cesarean Deliveries
-
Apr 26, 2026, 07:37Göksu Dirgin: Privileged to Be Part of the 6th International Congress EBART 2026
-
Apr 26, 2026, 06:57Embryological Outcomes of Using Surgical Sperm in Obstructive and Nonobstructive Azoospermia – Fertility and Sterility